How Tirzepatide Dose Escalation Affects Your Monthly Cost

Tirzepatide is not a flat-rate medication. What you pay per month depends on which dose your prescriber has you on, which provider you use, and how far into the escalation schedule you are. A patient starting at 2.5 mg might pay $129 through a compounded provider or $299 through LillyDirect. Six months later at 10 mg, those numbers could look identical or jump by $300 depending on the pricing model. This page maps out the cost at every dose level, explains the standard escalation timeline, and projects what a full year of treatment actually costs.

How Tirzepatide Dosing Works

The Standard Escalation Schedule

The FDA prescribing information for Zepbound (NDA 217806) lays out a specific dose escalation path. Treatment starts at 2.5 mg injected once weekly for a minimum of four weeks. The dose then increases to 5 mg weekly for at least another four weeks. From there, the prescriber may increase by 2.5 mg increments every four or more weeks based on the patient's response and tolerability. The approved maintenance doses are 5 mg, 10 mg or 15 mg weekly. Every dose decision should be made by your prescriber based on your individual response. We cover doses here only as they relate to pricing.

Why Doses Increase Over Time

The escalation schedule exists to manage tolerability. Gastrointestinal side effects, primarily nausea, are the most commonly reported adverse events in clinical trials, and they tend to peak during dose increases. The SURMOUNT-1 trial found that most gastrointestinal events were mild to moderate and occurred during the escalation period (PMID 35658024, NEJM 2022). Starting low and increasing gradually gives the body time to adjust. From a cost perspective, this means your first two to three months of treatment are at lower-priced dose tiers with most providers, which reduces the initial financial commitment.

Cost at Each Dose Level

The table below compares monthly pricing across three major routes at each dose tier. All prices verified October 2026.

Sources: BiltRx pricing from biltrx.com (verified 22 Oct 2026; excludes consultation and shipping fees). Arc-1 pricing from arc-1.co (verified 22 Oct 2026; includes consultation and shipping). Zepbound self-pay from LillyDirect (October 2026; 45-day refill window pricing). Mounjaro self-pay is a flat $499 at all doses through LillyDirect. Zepbound WAC is $1,086/mo and Mounjaro WAC is $1,112/mo regardless of dose.

The critical takeaway: BiltRx charges the same $129 whether you are on 2.5 mg or 15 mg. Arc-1 and Zepbound both increase with dose, though Zepbound caps at $449 for 7.5 mg through 15 mg when you maintain the 45-day refill window. The pricing model you choose determines whether dose escalation affects your monthly bill.

Staying on a Lower Dose to Save Money

When the price jumps by $100 or $200 per month at the next dose tier, patients naturally ask whether they can stay on a lower dose. The answer depends on what your prescriber recommends, but the clinical data provides useful context.

What the Prescribing Information Says

The Zepbound label lists 5 mg, 10 mg and 15 mg as maintenance doses. The 2.5 mg dose is explicitly a starting dose, not a maintenance dose. Your prescriber determines the appropriate maintenance level based on your response, tolerability and treatment goals. We are not suggesting anyone adjust their own dose to save money. But understanding the data behind each dose level helps you have an informed conversation with your provider about where the clinical benefit plateaus relative to the cost increase.

Efficacy at Lower Doses (SURMOUNT-1 Data)

The SURMOUNT-1 trial provides dose-specific weight loss data (PMID 35658024, NEJM 2022). At 72 weeks: the 5 mg dose produced 15.0% body weight loss, 10 mg produced 19.5% and 15 mg produced 20.9%. Placebo produced 3.1%. The jump from 5 mg to 10 mg adds 4.5 percentage points of weight loss. The jump from 10 mg to 15 mg adds only 1.4 percentage points. This diminishing return at higher doses is relevant to the cost conversation.

For a patient on Arc-1 choosing between 5 mg at $249.99 and 7.5 mg at $399.99, the additional $150 per month buys incremental efficacy that narrows at each step. On BiltRx at $129 regardless of dose, there is no cost penalty for escalation. On Zepbound self-pay, the jump from $399 at 5 mg to $449 at 7.5 mg and above is only $50, making dose escalation relatively affordable. The financial pressure to stay low is strongest with dose-tiered compounded providers. Discuss the clinical appropriateness of any dose decision with your prescriber. Our compounded tirzepatide price page compares annual costs at each dose level.

The Long-Term Cost Picture

Tirzepatide is not a short-term treatment. Most patients stay on the medication indefinitely to maintain weight loss. Planning for the cost trajectory over months and years is essential to avoiding treatment interruptions caused by financial surprise.

Months 1-3: Escalation Phase

The first three months are the cheapest with dose-tiered providers. At BiltRx: $129 per month for all three months ($387 total plus fees). At Arc-1: $199.99 for month one (2.5 mg), $199.99 for month two (2.5 mg), $249.99 for month three (5 mg), totaling $649.97. At Zepbound self-pay: $299, $299, $399, totaling $997. This escalation phase is when treatment costs the least and side effects are most likely to surface. It is also when patients often decide whether the medication works well enough to justify the long-term investment.

Months 4-12: Maintenance Stabilization

By month four, most patients have reached a maintenance dose. If that dose is 5 mg, the remaining nine months cost $1,161 on BiltRx ($129 x 9), $2,249.91 on Arc-1 ($249.99 x 9), or $3,591 on Zepbound self-pay ($399 x 9). If maintenance lands at 10 mg or 15 mg, BiltRx stays flat, Arc-1 does not currently list those doses, and Zepbound self-pay rises to $449 per month ($4,041 for nine months). First-year totals range from roughly $1,548 on BiltRx to $4,588 on Zepbound self-pay at 5 mg maintenance. See our monthly cost breakdown for a complete 12-month projection.

Year 2+: Ongoing Treatment

Year two and beyond is straightforward: twelve months at your maintenance dose. At $129 per month on BiltRx, that is $1,548 per year plus fees. At $449 per month on Zepbound self-pay at a higher maintenance dose, that is $5,388 per year. Over five years, the difference between BiltRx and Zepbound self-pay at higher doses exceeds $19,000. These projections assume stable pricing, which is not guaranteed. Lilly could adjust self-pay rates, compounded providers could change their pricing, and regulatory changes could affect compounded availability. Budget conservatively and revisit options annually. Our cheapest tirzepatide ranking is updated as prices change.